TwentyTwentyTweetsTweets by 2020health
Join 7,195 other subscribers
Category Archives: Innovation
Baby Boomer women and tech – new report
Guest blog by Kathy Mason Associate, 2020health Elder care with technology appeals most to Baby Boomer women Two thirds of 55-75 year olds would be interested in using technology to help their parents as they get older. Help with medication, memory, … Continue reading
What can be done to help rocket boost MedTech into everyday healthcare?
Guest Blog by Dr Michelle Tempest, Partner at Candesic, Health & Social Care Consultancy Despite MedTech being central to the future of healthcare, digital implementation often struggles to get into the top 3 priorities of stakeholders who have to contend … Continue reading
Posted in A&E, Department of Health, Hospitals, Innovation, NHS, NHS IT, Telehealth Tagged MedTech, NHS Leave a comment
The Dynamic Shift: People want to access MedTech at home
Guest Blog by Dr Michelle Tempest, Partner at Candesic, Health & Social Care Consultancy One of the most important paradigms in healthcare is the fundamental shift in the doctor-patient axis. The old fashioned paternalistic doctor-patient relationship, where the doctor held … Continue reading
Posted in Department of Health, Hospitals, Innovation, NHS, NHS IT, Patients, Telehealth Tagged digital health, MedTech, Professor Eric Topol Leave a comment
2016: The Year for UK Medical Technology (MedTech)
Guest Blog by Dr Michelle Tempest, Partner at Candesic, Health & Social Care Consultancy Technology is everywhere. Your mobile phone is probably close at hand ready to break down the physical barriers of bricks and mortar. Technology rapidly advances in … Continue reading
Posted in Department of Health, Hospitals, Innovation, NHS, NHS IT, Technology, Telehealth Tagged digital, MedTech, NHS Leave a comment
Industry View – Patients are good at caring for themselves
Guest Blog by David Patterson, founder of Helicon Health, emeritus professor of cardiovascular medicine, University College London and consultant cardiologist, Whittington Health. A blog, written for Digital Health by a highly experienced consultant cardiologist, struck a chord with us so we … Continue reading
Psychology in digital health: It’s the missing piece of the jigsaw…
Guest blog by Jessica Auton from Aseptika Ltd (Activ8rlives), winners of the ‘Manage My Condition’ Category in this year’s AXA PPP ‘Health Tech & You’ Awards The psychology of self-management and the impact of digital technology: With the shift towards self-monitoring utilising digital healthcare, … Continue reading
Health Tech and You: Helping to reach a tipping point
By Matt James, Senior Researcher at 2020health In our previous blog we were looking at the value of the personalised health agenda. But having vision and developing policy based on that vision is one thing. Identifying the ‘how to’ steps to … Continue reading
Health Tech and You: Leading in the personalisation of health care
By Matt James, Senior Researcher at 2020health The weather might have not have been particularly spring like but the Design Museum certainly lit up the waterfront beside the Thames in a vivid display promoting the Health Tech and You Awards … Continue reading
Are pharmaceutical mega-mergers in the public interest?
The main reason for governments around the world to encourage the pharmaceutical industry is to support Research and Development – R&D – with a view to the discovery of new drugs of future benefit to mankind. Commercial pharmaceutical companies have played … Continue reading
Posted in Business, competition, Drugs, Innovation, International, Pharma, Policy, Research, Technology Tagged 2020health, AstraZeneca, Beecham, Boots, competition, David Jack, Drugs, Glaxo, innovation, Keith Mansford, medicine, merger, Pfizer, pharmaceutical, R&D, Research, Sir David Jack, SmithKline, Smithkline Beecham, Tagamet, takeover Leave a comment
Medical advisory body “NICE” should not spend too much time valuing drugs.
The UK National Institute for Health and Care Excellence (“NICE”) is currently holding a public consultation over its proposals for evaluating drugs. Drugs that are approved by NICE automatically become available for doctors to prescribe under the NHS throughout England … Continue reading
Posted in Business, CCGs, Commissioning, Department of Health, Drugs, Elderly, equality, Genetics, GPs, Health and Wellbeing, Health Bill, Health reform, Inequality, Innovation, Jeremy Hunt, NHS, NHS reforms, Patients, Pharma, Policy, Public Health, Research, Technology, Uncategorized, Wellbeing Tagged 2020health, Clinical Commissioning Group, Commissioning, Department of Health, dose, elderly, General practitioner, government, GP, GPs, health, Health Bill, innovation, Jeremy Hunt, medicine, Medicines and Healthcare products Regulatory Agency, MHRA, National Health Service, National Institute for Health and Care Excellence, NHS, NICE, Old age, patient, Patients, pharmaceutical, PPRS, pricing, Proportionate QALY, Public Health, QALY, R&D, Research, value-based, value-based pricing Leave a comment
You must be logged in to post a comment.